These are the main areas of work for research and innovation in health
Drug resistance is a major obstacle in the treatment of infectious diseases worldwide.
There is a need for considerable efforts in research, through funding and better coordination among European countries.
A group of diseases characterised by uncontrolled growth and spread of abnormal cells.
Cardiovascular diseases (CVD) are one of Europe's largest health problems.
Chronic conditions are major causes of disability, ill-health, health-related retirement and premature death.
This disease, characterised by abnormal blood sugar levels, represents a growing threat to human health.
The EU is boosting its investment in Ebola research aiming at further achieving life-changing results.
Research on EIDs has been included in the Commission Framework Programmes for Research since their very inception.
Public health research will lead the way in providing evidence for the best health practices.
The European Commission considers HIV/AIDS a top priority and has significantly invested in HIV/AIDS research.
Chronic conditions and diseases are major causes of disability, ill-health, health-related retirement and premature death.
Malaria, a preventable and treatable disease, is one of the world's deadliest diseases.
Rare diseases are life-threatening and chronically debilitating diseases.
M. tuberculosis is one of the most successful pathogens ever encountered and the EU has invested a total of € 118 million in 50 projects.
The EU is investing €45 million in research to fight outbreaks caused by emerging infections such as the Zika virus.